# A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

> **NCT05784363** · PHASE1 · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Enlarged Pores
- Sebum Production

## Interventions

- **DRUG:** NT 201
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05784363
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-27
- **Primary completion:** 2024-06-17
- **Final completion:** 2024-07-31
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05784363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05784363, "A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05784363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*